Veerhealth Care Limited (VEERHEALTH.BO)
INR 14.9
(3.98%)
INR 14.9
(3.98%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 49.57 Million INR | -48.16% |
| 2022 | 39.97 Million INR | 52.08% |
| 2021 | 26.28 Million INR | -11.43% |
| 2020 | 29.67 Million INR | -20.51% |
| 2019 | 37.33 Million INR | 73.72% |
| 2018 | 21.49 Million INR | 46.98% |
| 2017 | 14.62 Million INR | 94.31% |
| 2016 | 7.52 Million INR | -32.26% |
| 2015 | 11.1 Million INR | 121.76% |
| 2014 | 5 Million INR | 446.88% |
| 2013 | -1.44 Million INR | 28.12% |
| 2012 | -2 Million INR | -381.37% |
| 2011 | 714.01 Thousand INR | -13.66% |
| 2010 | 827 Thousand INR | -93.99% |
| 2009 | 13.76 Million INR | 0.0% |
| 2008 | - INR | -100.0% |
| 2007 | 629 Thousand INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 2.75 Million INR | 86.12% |
| 2023 Q1 | 12.85 Million INR | 16.1% |
| 2023 FY | 20.72 Million INR | -48.16% |
| 2023 Q4 | 4.24 Million INR | -54.27% |
| 2023 Q3 | 9.27 Million INR | -26.55% |
| 2023 Q2 | 12.62 Million INR | -1.72% |
| 2022 Q3 | 8.84 Million INR | -19.61% |
| 2022 FY | 39.97 Million INR | 52.08% |
| 2022 Q1 | 10.52 Million INR | 89.95% |
| 2022 Q2 | 11 Million INR | 4.61% |
| 2022 Q4 | 11.06 Million INR | 25.08% |
| 2021 FY | 26.28 Million INR | -11.43% |
| 2021 Q1 | 7.67 Million INR | 99.25% |
| 2021 Q2 | 6.39 Million INR | -16.68% |
| 2021 Q3 | 6.67 Million INR | 4.43% |
| 2021 Q4 | 5.54 Million INR | -17.04% |
| 2020 Q1 | 5.09 Million INR | -52.41% |
| 2020 Q4 | 3.85 Million INR | -61.89% |
| 2020 Q3 | 10.1 Million INR | -4.84% |
| 2020 Q2 | 10.62 Million INR | 108.3% |
| 2020 FY | 29.67 Million INR | -20.51% |
| 2019 FY | 37.33 Million INR | 73.72% |
| 2019 Q4 | 10.71 Million INR | 47.69% |
| 2019 Q3 | 7.25 Million INR | -37.81% |
| 2019 Q2 | 11.66 Million INR | 46.55% |
| 2019 Q1 | 7.96 Million INR | 220.32% |
| 2018 FY | 21.49 Million INR | 46.98% |
| 2018 Q4 | 2.48 Million INR | -69.27% |
| 2018 Q3 | 8.08 Million INR | 39.14% |
| 2018 Q2 | 5.81 Million INR | 18.52% |
| 2018 Q1 | 4.9 Million INR | 3529.37% |
| 2017 Q1 | 2.43 Million INR | 1099.01% |
| 2017 Q2 | 6.51 Million INR | 167.5% |
| 2017 Q3 | 6.11 Million INR | -6.14% |
| 2017 Q4 | -143 Thousand INR | -102.34% |
| 2017 FY | 14.62 Million INR | 94.31% |
| 2016 Q2 | 2.75 Million INR | -6.16% |
| 2016 FY | 7.52 Million INR | -32.26% |
| 2016 Q4 | 203 Thousand INR | -93.85% |
| 2016 Q3 | 3.29 Million INR | 19.66% |
| 2016 Q1 | 2.93 Million INR | 100.27% |
| 2015 Q1 | 2.05 Million INR | 1806.48% |
| 2015 Q2 | 3.99 Million INR | 93.98% |
| 2015 Q3 | 6 Million INR | 50.3% |
| 2015 Q4 | 1.46 Million INR | -75.56% |
| 2015 FY | 11.1 Million INR | 121.76% |
| 2014 Q1 | 100 Thousand INR | 106.05% |
| 2014 FY | 5 Million INR | 446.88% |
| 2014 Q2 | 1.57 Million INR | 1473.0% |
| 2014 Q3 | 3.1 Million INR | 97.14% |
| 2014 Q4 | 108 Thousand INR | -96.52% |
| 2013 Q1 | - INR | 100.0% |
| 2013 FY | -1.44 Million INR | 28.12% |
| 2013 Q4 | -1.65 Million INR | -4235.0% |
| 2013 Q3 | 40 Thousand INR | -76.61% |
| 2013 Q2 | 171 Thousand INR | 0.0% |
| 2012 Q2 | 2.68 Million INR | 0.0% |
| 2012 FY | -2 Million INR | -381.37% |
| 2012 Q1 | - INR | 100.0% |
| 2012 Q3 | 17 Thousand INR | -99.37% |
| 2012 Q4 | -4.71 Million INR | -27811.45% |
| 2011 Q4 | -3.65 Million INR | 0.0% |
| 2011 FY | 714.01 Thousand INR | -13.66% |
| 2011 Q3 | - INR | 0.0% |
| 2010 FY | 827 Thousand INR | -93.99% |
| 2009 FY | 13.76 Million INR | 0.0% |
| 2008 Q4 | - INR | 0.0% |
| 2008 FY | - INR | -100.0% |
| 2007 FY | 629 Thousand INR | 0.0% |
| 2007 Q4 | - INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| DECIPHER LABS LIMITED | 331.34 Million INR | 85.038% |
| Gujarat Themis Biosyn Limited | 1.28 Billion INR | 96.134% |
| Ishita Drugs and Industries Limited | 38.94 Million INR | -27.305% |
| MedPlus Health Services Limited | 12.33 Billion INR | 99.598% |
| ANG Lifesciences India Limited | 232.73 Million INR | 78.699% |
| Add-Shop E-Retail Limited | 224.09 Million INR | 77.878% |
| Bacil Pharma Limited | -19.95 Thousand INR | 248591.228% |
| BDH Industries Limited | 175.55 Million INR | 71.762% |
| Beryl Drugs Limited | 108.5 Million INR | 54.311% |
| Cian Healthcare Limited | 113.16 Million INR | 56.194% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -169.688% |
| Concord Drugs Limited | 116.7 Million INR | 57.522% |
| Deccan Health Care Limited | 221.57 Million INR | 77.626% |
| Gujarat Terce Laboratories Limited | 141.4 Million INR | 64.943% |
| Hindustan Bio Sciences Limited | 3.14 Million INR | -1478.668% |
| Jenburkt Pharmaceuticals Limited | 1.1 Billion INR | 95.527% |
| KIMIA BIOSCIENCES LIMITED | 111.76 Million INR | 55.644% |
| Kwality Pharmaceuticals Limited | 1.43 Billion INR | 96.55% |
| Makers Laboratories Limited | 308.54 Million INR | 83.933% |
| Medi-Caps Limited | 68.09 Million INR | 27.196% |
| Panchsheel Organics Limited | 356.44 Million INR | 86.092% |
| Parmax Pharma Limited | 99.31 Million INR | 50.085% |
| Parnax Lab Limited | 552.1 Million INR | 91.021% |
| Patidar Buildcon Limited | -26 Thousand INR | 190769.231% |
| Phaarmasia Limited | 38.89 Million INR | -27.472% |
| Vikram Thermo (India) Limited | 443.73 Million INR | 88.828% |
| Sanjivani Paranteral Limited. | 208.87 Million INR | 76.266% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 12310.345% |
| Smruthi Organics Limited | 324.76 Million INR | 84.735% |
| Source Natural Foods and Herbal Supplements Limited | 66.01 Million INR | 24.902% |
| SUDARSHAN PHARMA INDUSTRIES LI | 361.76 Million INR | 86.297% |
| Trident Lifeline Limited | 119.08 Million INR | 58.37% |
| Transchem Limited | -8.96 Million INR | 652.911% |
| Trinity League India Limited | 1.23 Million INR | -3923.864% |
| Tyche Industries Limited | 290.84 Million INR | 82.955% |
| Vista Pharmaceuticals Limited | 10.02 Million INR | -394.75% |
| Vivanza Biosciences Limited | 19.38 Million INR | -155.707% |
| PRAVEG LIMITED | 266.99 Million INR | 81.433% |
| Sastasundar Ventures Limited | 1.19 Billion INR | 95.867% |
| Sunil Healthcare Limited | 247.86 Million INR | 80.0% |
| Syschem (India) Limited | 569.04 Million INR | 91.288% |
| Zenith Healthcare Limited | 46.17 Million INR | -7.363% |
| Zenlabs Ethica Limited | 147.75 Million INR | 66.448% |
| Mercury Laboratories Limited | 279.39 Million INR | 82.256% |
| SHELTER PHARMA LIMITED | 110.97 Million INR | 55.327% |
| Vasundhara Rasayans Limited | 207.68 Million INR | 76.13% |
| Bharat Immunologicals & Biologicals Corporation Limited | -146.67 Million INR | 133.798% |
| Roopa Industries Limited | 72.95 Million INR | 32.047% |
| PANJON LTD. | 33.77 Million INR | -46.76% |
| Pharmaids Pharmaceuticals Limited | -72.81 Million INR | 168.079% |
| TIAAN CONSUMER LIMITED | -17.81 Million INR | 378.349% |
| Anuh Pharma Limited | 1.6 Billion INR | 96.908% |
| Crestchem Limited | 51.53 Million INR | 3.81% |
| Emmessar Biotech & Nutrition Limited | -7.43 Million INR | 766.945% |
| Sandu Pharmaceuticals Limited | 347.1 Million INR | 85.718% |
| Fredun Pharmaceuticals Limited | 724.71 Million INR | 93.16% |
| Trimurthi Limited | 1.95 Million INR | -2440.953% |
| Shukra Pharmaceuticals Limited | 300.38 Million INR | 83.497% |
| Norris Medicines Limited | 29.36 Million INR | -68.835% |
| Lactose (India) Limited | 230.3 Million INR | 78.475% |
| OXYGENTA PHARMACEUTICAL LIMITE | -99.79 Million INR | 149.677% |
| Ambalal Sarabhai Enterprises Limited | 717.63 Million INR | 93.092% |
| Gennex Laboratories Limited | 276.99 Million INR | 82.103% |
| Denis Chem Lab Limited | 596.24 Million INR | 91.686% |
| Colinz Laboratories Limited | 16.35 Million INR | -203.112% |
| Godavari Drugs Limited | 359.01 Million INR | 86.191% |
| Zenotech Laboratories Limited | 337.19 Million INR | 85.298% |
| Shree Ganesh Remedies Limited | 674.17 Million INR | 92.647% |
| Bharat Parenterals Limited | 989.46 Million INR | 94.99% |
| Coral Laboratories Limited | 332.39 Million INR | 85.086% |
| Evoq Remedies Limited | 47.43 Million INR | -4.512% |
| Kerala Ayurveda Limited | 447.69 Million INR | 88.927% |
| KOBO BIOTECH LIMITED | -40.71 Million INR | 221.762% |
| Natural Capsules Limited | 557.1 Million INR | 91.101% |
| Auro Laboratories Limited | 249.39 Million INR | 80.122% |